It is with great grief that we announce the loss of our friend and mentor, Professor Ovidiu Alexandru Băjenaru. It would be difficult to write of our beloved colleague in these pages without betraying emotion. A brilliant neurologist, researcher, teacher, husband, father, he leaves behind a profound legacy of perhaps the most influential contemporary figure in Romanian neurology.
Category
Top Articles
-
-
Executive PageEAN NewsTop ArticlesFeatured Slider
Executive Page: Matthias Endres elected as new Member-at-Large
September 1, 2020Matthias Endres, new Member at Large By Matthias Endres Dear Colleagues and Friends, It is indeed a great honour for me to be elected as a new Member-at-Large of the EAN board. Especially in these times of great uncertainty both… Continue Reading
-
Paper of the MonthEAN NewsTop Articles
Research Paper of the Month: “Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer’s Disease”
August 4, 2020For August 2020, we have selected Turner R.S. et al. “Nilotinib Effects on Safety, Tolerability,and Biomarkers in Alzheimer’s Disease” Annals of Neurology 2020;88:183–194. doi: 10.1002/ana.25775. Epub 2020 May 28. -
Executive PageEAN NewsTop ArticlesFeatured Slider
Executive Page: Thomas Berger, Chair of the Scientific Committee
August 1, 2020Executive Page: Thomas Berger, Chair of the Scientific Committee -
Paper of the MonthEAN NewsTop ArticlesFeatured Slider
Covid-19 Paper of the Month: “Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic”
August 1, 2020For August 2020, we have selected Rogers J.P. et al. “Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic” Lancet Psychiatry 2020; 7:611-627. -
News from EAN member societiesEAN NewsCOVID-19Other NewsTop Articles
EDITORIAL: COVID 19 AND NEUROLOGY – Turkish Neurological Society
July 15, 2020The COVID-19 Pandemic and Neurology Published by the Turkish Neurological Society COVID-19 COMMITTEE -
Research HighlightsEAN NewsCOVID-19ResearchTop Articles
Neurology Update: Epilepsy & Covid-19
July 14, 2020Acute symptomatic seizures and SARS-CoV-2 encephalitis in COVID-19 -
Research HighlightsEAN NewsCOVID-19ResearchTop Articles
Neurology Update: COVID-19 & Neuroscience/ Translational neurology
July 7, 2020COVID Breaking news: CNS injury biomarkers elevated in COVID patients -
Estonia is a small country in Northeastern Europe, the northernmost of the three Baltic states.
-
Paper of the MonthEAN NewsTop ArticlesFeatured Slider
Paper of the month: Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke
July 3, 2020For July 2020, we have selected: Yang P. et al. Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke -
Executive PageEAN NewsTop ArticlesFeatured Slider
Executive Page: Elena Moro elected as Secretary General
July 3, 2020A letter from Elena Moro as new Secretary General -
Breaking newsCOVID-19Eur J NeurolTop Articles
BREAKING NEWS: A systematic review of neurological manifestations of SARS‐CoV‐2 infection: the devil is hidden in the details
June 30, 2020Members of the EAN Scientific Panel on Infectious Diseases have recently published a systematic review of neurological manifestations of SARS‐CoV‐2 infection in the European Journal of Neurology. -
SurveysEAN NewsResearchTop ArticlesUncategorized
SURVEY: Driving with an intracranial tumor
June 25, 2020EAN Scientific Panel Neuro-oncology invites you to take part in their survey: -
The first case of COVID-19 infection was recorded in Brazil on Feb 25, 2020. On June 20th, official statistics reported 1 million confirmed cases, and more than 50,000 deaths. Brazil has the second highest number of cases of COVID-19 in the world, facing more than 1,000 deaths per day. However, due to underreporting among many regions in the country, the actual numbers are unknown. Besides the underestimation of the real deaths and cases, the Government recently changed the way in which the cases were reported: only new cases were reported, and not the total number of infected people or deaths. This has produced great criticism from the scientific community and the media, increasing the levels of tension under which the country has been living.
-
Breaking newsEAN NewsCOVID-19ResearchTop Articles
Breaking News: Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
June 23, 2020In this paper, just published in Lancet, the authors performed a dose-escalation, single-centre, open-label, non-randomised, phase 1 trial of a recombinant adenovirus type-5 (Ad5) vectored COVID-19 vaccine in Wuhan, China.